|1.||Trasande, Leonardo: 2 articles (04/2015 - 04/2015)|
|2.||Hauser, Russ: 2 articles (04/2015 - 02/2013)|
|3.||Shimizu, Tomomi: 2 articles (05/2010 - 04/2010)|
|4.||Watanabe, Wataru: 2 articles (05/2010 - 04/2010)|
|5.||Sawamura, Rie: 2 articles (05/2010 - 04/2010)|
|6.||Kurokawa, Masahiko: 2 articles (05/2010 - 04/2010)|
|7.||Konno, Katsuhiko: 2 articles (05/2010 - 04/2010)|
|8.||Hino, Akane: 2 articles (05/2010 - 04/2010)|
|9.||Xu, Ying: 2 articles (05/2009 - 06/2007)|
|10.||Ilbäck, Nils-Gunnar: 2 articles (01/2009 - 06/2005)|
07/01/2012 - "In the present study, we evaluated the cyto- and genotoxicity of 2,2',4,4'-tetrabromodiphenyl ether (BDE-47) and decabrominated diphenyl ether (BDE-209) in human neuroblastoma cells (SK-N-MC). "
08/01/2008 - "In this study, we investigated the action of a commercial mixture of PBDEs (pentabrominated diphenyl ether, DE-71) on a human neuroblastoma cell line, SK-N-SH. "
09/01/2013 - "Murine N2A and human SK-N-AS neuroblastoma cells and murine preadipocyte fibroblasts (3T3-L1) were exposed to tributyltin (TBT), diethylstilbestrol (DES), bisphenol A (BPA), 2,3,7,8-tetrachlorodibenzo-[p]-dioxin (TCDD), 2,2',4,4',5,5'-hexachlorobiphenyl (PCB-153), hexachlorobenzene (HCB), hexabromocyclododecane (HBCD), 2,2',4,4'-tetrabrominated diphenyl ether (BDE-47) , perfluorinated octyl acid (PFOA) and perfluorinated octyl sulfonate (PFOS). "
|2.||Hepatocellular Carcinoma (Hepatoma)
06/15/2007 - "This study was designed to determine the anti-proliferative, apoptotic properties of decabrominated diphenyl ether (PBDE-209), using a human hepatoma Hep G2 line as a model system. "
05/01/2009 - "Effects of tetrabrominated diphenyl ether and hexabromocyclododecanes in single and complex exposure to hepatoma HepG2 cells."
06/15/2007 - "Apoptosis induction on human hepatoma cells Hep G2 of decabrominated diphenyl ether (PBDE-209)."
01/01/2015 - "This finding is helpful to uncover the underlying mechanisms for the diphenyl ether derivatives and provides a potential application in fighting clinical fungal infections. "
05/01/2010 - "Functional disorder of primary immunity responding to respiratory syncytial virus infection in offspring mice exposed to a flame retardant, decabrominated diphenyl ether, perinatally."
05/01/2010 - "Perinatal exposure to a representative flame retardant, decabrominated diphenyl ether (DBDE), was shown previously to increase viral titers in the lungs of respiratory syncytial virus (RSV)-infected offspring on day 5 post-infection, resulting in exacerbation of pneumonia. "
01/30/2009 - "Polybrominated diphenyl ether exposure suppresses cytokines important in the defence to coxsackievirus B3 infection in mice."
06/01/2005 - "Common viral infection affects pentabrominated diphenyl ether (PBDE) distribution and metabolic and hormonal activities in mice."
04/01/2012 - "Effects of decabrominated diphenyl ether (PBDE-209) in regulation of growth and apoptosis of breast, ovarian, and cervical cancer cells."
12/16/1998 - "Adipose tissue levels of tetra-BDE (2,2',4,4' tetra-brominated diphenyl ether) were measured in 42 male or female cancer patients [19 with non-Hodgkin's lymphoma (NHL), 23 with malignant melanoma (MM)], and in 27 controls without a diagnosis of cancer. "
03/01/2011 - "Most importantly, diphenyl-ether inhibitors have been found recently to possess the potential in Photodynamic therapy (PDT) to treat cancer. "
|1.||pentabromodiphenyl ether (PBDE)
|2.||Halogenated Diphenyl Ethers
|3.||Flame Retardants (Fire Retardants)
|5.||Dust (House Dust)
|7.||Polychlorinated Biphenyls (PCBs)
|10.||Phenol (Carbolic Acid)
|1.||Photochemotherapy (Photodynamic Therapy)